Search clinical trials for: Imatinib Mesylate intravenous solution

Total 1646 results

University of Cologne
Sanofi; Novartis; Roche Pharma AG

Completed

First-line Therapy of Stage IV Colorectal Cancer

Stage IV Colorectal Cancer

Germany
National Institute of Allergy and Infectious Diseases...

Terminated

Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa

Loiasis

Cameroon
AstraZeneca

Completed

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania (ANCHOR 149)

Bipolar Disorder

United States
Peking University

Unknown

To Compare the Efficacy of Surgery Followed by Sunitinib With Surgery Followed by Imatinib in GIST Patients With Progression on Imatinib.

GIST

China
Novartis Pharmaceuticals

Completed

Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Chronic Myeloid Leukemia (CML)

Korea, Republic of
Rare Disease Research, LLC
Sarepta Therapeutics, Inc.

Terminated

An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

United States
Clinica Universidad de Navarra, Universidad de...

Completed

Prevention of Contrast Induced Nephropathy (NIC) by Intravenous Versus Oral Rehydration (NIC)

KIDNEY FAILURE, ACUTE

Spain
New Mexico Cancer Care Alliance

Completed

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Cancer | Leukemia, Other

United States
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer

Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma

China
Christian Hassager

Completed

IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest (IMICA)

Systemic Inflammatory Response Syndrome | Heart Arrest | Out-Of-Hospital Cardiac Arrest

Denmark
Boehringer Ingelheim

Completed

Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers

Healthy
Sun Yat-sen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

Metastatic Biliary Tract Cancer | Locally Advanced Biliary Tract Cancer

China
Wei Jiang
Wuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital of Baise and other collaborators

Unknown

Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Novartis Pharmaceuticals

Completed

A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.

Rheumatoid Arthritis

Austria, United Kingdom, Canada, Finland
Peking University Cancer Hospital & Institute

Unknown

A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma

Advanced Melanoma

China
Zhengzhou University

Unknown

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Newly Diagnosed Peripheral T-cell Lymphoma

China
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia

Canada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
University of Campinas, Brazil

Active, not recruiting

Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response (EDI-PIO)

Leukemia, Chronic Myeloid

Brazil
University of Utah
Schering-Plough

Terminated

Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients

Gastrointestinal Stromal Tumors | Solid Tumors | Cancer Brain

United States
Changzhou Cancer Hospital of Soochow University

Completed

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer (EASE)

Non-small Cell Lung Cancer

China
AstraZeneca

Completed

Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic

Schizophrenia

China
Novartis Pharmaceuticals

Completed

A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

3rd Line GIST

France, United Kingdom, Belgium, Canada, Spain, Netherlands, Japan, United States
Carol Davila University of Medicine and Pharmacy
S.C. Sanador S.R.L

Active, not recruiting

Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD

Endothelial Dysfunction | Oxidative Stress | Renal Anemia | Iron Toxicity

Romania
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

Ovarian Cancer
Nepal Health Research Council
Fogarty International Center of the National Institute of Health

Recruiting

Enteral Resuscitation Nepal

Burn Shock | Burn Body Region Unspecified

Nepal
University of Washington
Fogarty International Center of the National Institute of Health

Completed

Enteral Resuscitation Nepal (Pilot Study)

Burn Shock | Burn Body Region Unspecified

Nepal
Poznan University of Medical Sciences

Completed

PKPD of Rocuronium and Sugammadex Profile in Pediatric Patients

General Anesthetic Drug Adverse Reaction

Poland
National Institute of Allergy and Infectious Diseases...
University of Pennsylvania; Emory University; University of Florida; Aurum Institute

Completed

A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin (IMPACT-TB)

Tuberculosis

United States
Nurex S.r.l.
Purdue University; Università degli Studi di Sassari; Vinmec Healthcare System

Unknown

Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites (Artesynib)

Plasmodium Falciparum Malaria (Drug Resistant)

Vietnam
Eisai Korea Inc.

Completed

A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants

Locally Advanced or Metastatic Breast Cancer

Korea, Republic of
AEterna Zentaris
M.D. Anderson Cancer Center

Completed

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

Gastrointestinal Stromal Tumors
University of Bologna
Novartis

Completed

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) (CML022)

Chronic Myeloid Leukemia

Italy
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection

Hepatocellular Carcinoma

China
Elevar Therapeutics

Completed

A Study to Evaluate Apatinib (Also Known as Rivoceranib) Plus Nivolumab in Participants With Unresectable or Metastatic Cancer

Cancer

United States
Beijing Tsinghua Chang Gung Hospital

Unknown

Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer

Hepatocellular Carcinoma
Daniela Matei, MD
Sanofi; Novartis Pharmaceuticals; Walther Cancer Institute

Completed

Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer

Ovarian Cancer

United States
Fujian Cancer Hospital

Recruiting

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Immunotherapy | Gastrict Cancer

China
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

Gastrointestinal Stromal Tumors

Taiwan, Japan, China, Australia, Singapore
Oswaldo Cruz Foundation
Instituto Fernandes Figueira

Completed

Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

Hyperbilirubinemia | Erythroblastosis, Fetal

Brazil
University of British Columbia

Terminated

Effects of Goal-directed Fluid Therapy on Post-operative Outcomes in Children Undergoing Scoliosis Repair (CardioQ-RP)

Scoliosis | Acute Kidney Injury

Canada
China Medical University, China

Recruiting

PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma

Gastric Cancer | AFP

China
Peking University Cancer Hospital & Institute

Unknown

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

Melanoma
University of Southern California
National Institute on Aging (NIA)

Completed

Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD (Allo)

Alzheimer Disease | Mild Cognitive Impairment

United States
Zhongshan Hospital Xiamen University

Unknown

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Hepatic Metastasis of Colorectal Cancer

China
Peking University People's Hospital
Chinese Sarcoma Study Group

Recruiting

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma (MAPAC)

Osteosarcoma | Chemotherapy Effect | Survival | Toxicity, Drug

China
Zhongshan Hospital Xiamen University

Recruiting

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

Ovarian Cancer

China
Shanghai Ninth People's Hospital Affiliated to...

Recruiting

Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma (IMplus)

Head and Neck Squamous Cell Carcinoma

China
Novartis Pharmaceuticals

Completed

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Pulmonary Arterial Hypertension

Germany, Belgium, United States, Lithuania, United Kingdom, Italy, Australia
Hoffmann-La Roche

Terminated

A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (LISAH)

Breast Cancer

Austria
Seoul National University Hospital

Completed

Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients

Hemodynamic Instability

Korea, Republic of

Search clinical trials for: Imatinib Mesylate intravenous solution

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations